Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MOXICLAV DRY POWDER FOR ORAL SUSPENSION 156.25 mg/5 ml - HSA Drug Approval Details

Approvals/HSA/MOXICLAV DRY POWDER FOR ORAL SUSPENSION 156.25 mg/5 ml

Approved

THERAPEUTIC

MOXICLAV DRY POWDER FOR ORAL SUSPENSION 156.25 mg/5 ml

Medochemie Ltd – Factory B (CYPRUS)🇸🇬 Health Sciences Authority

Approval Date: Jan 20, 1999
Approval ID: 0224932aeecc5dd1
Company: Medochemie Ltd – Factory B (CYPRUS)
Type: Therapeutic

Approval Details

Approval Id: 0224932aeecc5dd1
Drug Name: MOXICLAV DRY POWDER FOR ORAL SUSPENSION 156.25 mg/5 ml
Product Name: MOXICLAV DRY POWDER FOR ORAL SUSPENSION 156.25 mg/5 ml
Approval Number: SIN10690P
Approval Date: 1999-01-20
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
Licence Holder: MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: POWDER, FOR SUSPENSION
Route Of Administration: ORAL
Atc Code: J01CR02
Atc Item Name: amoxicillin and beta-lactamase inhibitor
Pharma Manufacturer Name: MEDOCHEMIE SINGAPORE PTE. LTD.

Active Ingredients

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

125 mg/5 ml

CLAVULANATE POTASSIUM EQV CLAVULANIC ACID

31.25 mg/5 ml

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

125 MG/5 ML

CLAVULANATE POTASSIUM EQV CLAVULANIC ACID

31.25 MG/5 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 20, 1999

Approval ID

0224932aeecc5dd1

Type

Therapeutic

Back to HSA Approvals